351 related articles for article (PubMed ID: 12118366)
41. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
[TBL] [Abstract][Full Text] [Related]
42. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.
Boyer Arnold N; Korc M
J Biol Chem; 2005 Jun; 280(23):21858-66. PubMed ID: 15811853
[TBL] [Abstract][Full Text] [Related]
43. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
44. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
[TBL] [Abstract][Full Text] [Related]
45. Control of Smad7 stability by competition between acetylation and ubiquitination.
Grönroos E; Hellman U; Heldin CH; Ericsson J
Mol Cell; 2002 Sep; 10(3):483-93. PubMed ID: 12408818
[TBL] [Abstract][Full Text] [Related]
46. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane.
Suzuki C; Murakami G; Fukuchi M; Shimanuki T; Shikauchi Y; Imamura T; Miyazono K
J Biol Chem; 2002 Oct; 277(42):39919-25. PubMed ID: 12151385
[TBL] [Abstract][Full Text] [Related]
47. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
[TBL] [Abstract][Full Text] [Related]
48. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
49. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
[TBL] [Abstract][Full Text] [Related]
50. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
51. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
52. Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling.
Yan X; Lin Z; Chen F; Zhao X; Chen H; Ning Y; Chen YG
J Biol Chem; 2009 Oct; 284(44):30097-104. PubMed ID: 19758997
[TBL] [Abstract][Full Text] [Related]
53. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation.
Choy L; Skillington J; Derynck R
J Cell Biol; 2000 May; 149(3):667-82. PubMed ID: 10791980
[TBL] [Abstract][Full Text] [Related]
54. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
Yan X; Zhang J; Pan L; Wang P; Xue H; Zhang L; Gao X; Zhao X; Ning Y; Chen YG
Mol Cell Biol; 2011 Sep; 31(18):3700-9. PubMed ID: 21791611
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor beta1 induces nuclear export of inhibitory Smad7.
Itóh S; Landström M; Hermansson A; Itoh F; Heldin CH; Heldin NE; ten Dijke P
J Biol Chem; 1998 Oct; 273(44):29195-201. PubMed ID: 9786930
[TBL] [Abstract][Full Text] [Related]
56. Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling.
Ibarrola N; Kratchmarova I; Nakajima D; Schiemann WP; Moustakas A; Pandey A; Mann M
BMC Cell Biol; 2004 Jan; 5():2. PubMed ID: 14728725
[TBL] [Abstract][Full Text] [Related]
57. Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway.
Zhu L; Wang L; Luo X; Zhang Y; Ding Q; Jiang X; Wang X; Pan Y; Chen Y
J Biol Chem; 2012 Nov; 287(47):39653-63. PubMed ID: 23027871
[TBL] [Abstract][Full Text] [Related]
58. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
[TBL] [Abstract][Full Text] [Related]
59. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
[TBL] [Abstract][Full Text] [Related]
60. Smad7 and Smad6 differentially modulate transforming growth factor beta -induced inhibition of embryonic lung morphogenesis.
Zhao J; Shi W; Chen H; Warburton D
J Biol Chem; 2000 Aug; 275(31):23992-7. PubMed ID: 10801843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
